
Armata Pharmaceuticals fell 56.9% from $7.03 to $3.03, behind the S&P 500's +4.7%. Its worst day was Nov 16 (−22.7%), and its low came Nov 17 at $2.66.
Nov 21, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Armata Pharmaceuticals shares fell 18.3%, while the S&P 500 rose 0.1%.
−18.3% · S&P 500 +0.1%
Armata Pharmaceuticals shares rose 24.3%, while the S&P 500 rose 0.7%.
+24.3%, the year's best day · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $-3.43 missed the $-0.19 estimate on $1.1M revenue (est. $1.0M).
+8.6% · S&P 500 −1.8%
Armata Pharmaceuticals closed at its highest level of the year, 110.5% above where the year started.
+18.4% · S&P 500 −0.7%
EPS of $-3.16 missed the $-0.39 estimate on $789,000.00 revenue.
−7.0% · S&P 500 +0.8%
Armata Pharmaceuticals shares rose 19.9%, while the S&P 500 fell 1.0%.
+19.9% · S&P 500 −1.0%
EPS of $-0.27 beat the $-0.45 estimate on $2.5M revenue (est. $504,000.00).
+11.8% · S&P 500 +0.7%
Armata Pharmaceuticals shares fell 20.7%, while the S&P 500 fell 0.5%.
−20.7% · S&P 500 −0.5%
EPS of $-0.24 beat the $-0.56 estimate on $3.2M revenue (est. $540,000.00).
+4.0% · S&P 500 −0.4%
Where it ended: a close of $3.03 on Nov 20, 2026.
Nothing in the past 12 months.
All ARMP dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ARMP and SPY from Benzinga historical bars. Not investment advice.